Exabis Library
Welcome to the e-CCO Library!
P487: The feasibility of a digital platform for improving disease management among patients with Ulcerative Colitis
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P487: Tofacitinib for the treatment of ulcerative colitis: Analysis of infection rates from the OCTAVE clinical programme
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P488 How reliable is the online medical information on paediatric inflammatory bowel diseases? 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P488: Does Statin use reduce the risk of J-pouch related complications in patients with inflammatory bowel disease?
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P488: Efficacy of pre-operative oral antibiotic prophylaxis for the prevention of wound infections in patients with Crohn's disease
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P488: IBS-type symptoms in patients with quiescent inflammatory bowel disease are unrelated to ongoing inflammation
 2016
 ECCO '16 Amsterdam
 Friday, 22 February 2019, 9:49 AM
P488: Perianal Crohn's disease in the biological era 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P488: Switch from intravenous to subcutaneous infliximab in patients with Inflammatory Bowel Disease: efficacy, safety and patients' acceptance
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P488: The COVID19 pandemic impact on Inflammatory Bowel Disease Patients Management in a Romanian Tertiary Gastroenterology Centre
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P488: Trends in corticosteroid (CS) use over time and following diagnosis in patients with Inflammatory Bowel Disease (IBD), using IBM® MarketScan®
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P489 Are patients with inflammatory bowel disease receiving an adequate immunisation? 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P489: Clinical experience with ustekinumab in selected Crohn's disease patients
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P489: Defective anti-microbial peptides expression in Crohn’s disease mucosa can be reversed by strengthening IL-22 signalling 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P489: Double-dose infliximab therapy in Crohn's disease: appropriate time to evaluate the efficacy, long-term efficacy and safety
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P489: Predicting mucosal state with faecal calprotectin in children with Crohn’s disease.
 2016
 ECCO '16 Amsterdam
 Friday, 22 February 2019, 9:49 AM
P489: Rescue treatment with original versus biosimilar infliximab in biologic-naïve patients with moderate-severe Ulcerative Colitis and corticosteroid failure
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P489: Surgery for enterocutaneous fistula: the strongest predictor of postoperative mortality in Crohn's disease patients
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P489: Temporal trends of colectomy for ulcerative colitis in the multi-drug era; a population based cohort study.
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P490 Assessment of body weight changes in patients with inflammatory bowel diseases initiating biologic therapy: A prospective cohort study 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P490: A pilot study of the electronic patient portal “Patient Knows Best” for monitoring biologic therapy in inflammatory bowel disease
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM